November 5, 2021
Life Sciences
  • The U.S. canceled a $600 million deal with Emergent BioSolutions, the vaccine manufacturer that ruined millions of Johnson & Johnson COVID-19 doses. The cancellation comes after Emergent’s manufacturing facilities in Baltimore were found to have produced millions of contaminated vaccine earlier this year, prompting a months-long shutdown. Emergent will forgo about $180 million due to the contract’s termination. (Articles here and here)